Ceyda Ekentok Atici
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ceyda Ekentok Atici has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Julide Akbuga
Department of Pharmaceutical Technology, School of Pharmacy, Istanbul Medipol University, 34815 İstanbul, Türkiye
3 shared publications - Mizgin Ermanoğlu
Marmara University
2 shared publications - Suna Ozbas-Turan
Marmara University
2 shared publications - Turgut Taşkın
Marmara Üniversitesi
2 shared publications - Ahmet Doğan
Marmara University, Turkey
1 shared publication - Asli Gül Acar
Uludag Üniversitesi
1 shared publication
Latest Publications
- Open Access
- 3 December 2024
- Published by The Turkish Chemical Society in Journal of the Turkish Chemical Society Section A: Chemistry
- Vol. 11 (4) , 1515-1526
Integrating of In Silico and In Vitro Approaches to Determine Biological Activities of Abelmoschus esculentus’s Seeds
The purpose of this study was to examine the antioxidant, anti-urease, and anticholinesterase properties of extracts from plant seeds, as well as their toxicity on normal cells. In addition, the goal of this work was to use an in silico and in vitro method to evaluate the biological activity and mechanism of action of A. esculentus. DPPH (2,2-diphenyl-1-picrylhydrazyl), CUPRAC (Cupric ion reducing antioxidant capacity), and FRAP (Ferric reducing antioxidant power) techniques were used to examine the antioxidant properties of plant extracts. The extracts' anticholinesterase, anti-urease, and cytotoxic activity were determined using the Ellman, Indophenol, and MTT techniques, respectively. Computer algorithms were used to estimate ADMET and molecular docking techniques for compounds in plant. When the antioxidant activity results were examined, it was determined that water (IC50:0.313 mg/mL) and ethanol (IC50:0.314 mg/mL) extract showed DPPH activities close to each other. It was determined that the water (7.780mM FeSO4/mg extract, 1.106 mM troloxE/mg extract) extract showed higher activity than the ethanol (3.420 mM FeSO4/mg extract, 0.343 mM troloxE/mg extract) extract in FRAP and CUPRAC experiments. Considering the enzyme inhibition results, it was determined that the water extract showed the highest anti-urease activity, while the ethanol extract showed the highest anticholinesterase activity. It was also determined that both extracts had no toxic effect on normal cell lines (L-929). Based on pkCSM values, procyanidin B1 and procyanidin B2 compounds have a low volume of distribution, whereas rutin and quercetin compounds have a high volume of distribution (VDss). Not all compounds were predicted to have mutagenic and hepatotoxicity effects. In terms of score and ligand efficiency, procyanidin B1, procyanidin B2, quercetin, and rutin compounds appear to be superior to the reference. The chemicals quercetin and procyanidin B2 are thought to be key players in the pathophysiology of oxidative stress. In this study, the fact that the seeds’ extracts have biological activity and have no toxic effects on normal cell lines suggests that the seeds can be used medicinally and nutritionally in the future.
- 3 December 2024
- Published by The Turkish Chemical Society in Journal of the Turkish Chemical Society Section A: Chemistry
- Vol. 11 (4) , 1515-1526
Open AccessIntegrating of In Silico and In Vitro Approaches to Determine Biological Activities of Abelmoschus esculentus’s Seeds
The purpose of this study was to examine the antioxidant, anti-urease, and anticholinesterase properties of extracts from plant seeds, as well as their toxicity on normal cells. In addition, the goal of this work was to use an in silico and in vitro method to evaluate the biological activity and mechanism of action of A. esculentus. DPPH (2,2-diphenyl-1-picrylhydrazyl), CUPRAC (Cupric ion reducing antioxidant capacity), and FRAP (Ferric reducing antioxidant power) techniques were used to examine the antioxidant properties of plant extracts. The extracts' anticholinesterase, anti-urease, and cytotoxic activity were determined using the Ellman, Indophenol, and MTT techniques, respectively. Computer algorithms were used to estimate ADMET and molecular docking techniques for compounds in plant. When the antioxidant activity results were examined, it was determined that water (IC50:0.313 mg/mL) and ethanol (IC50:0.314 mg/mL) extract showed DPPH activities close to each other. It was determined that the water (7.780mM FeSO4/mg extract, 1.106 mM troloxE/mg extract) extract showed higher activity than the ethanol (3.420 mM FeSO4/mg extract, 0.343 mM troloxE/mg extract) extract in FRAP and CUPRAC experiments. Considering the enzyme inhibition results, it was determined that the water extract showed the highest anti-urease activity, while the ethanol extract showed the highest anticholinesterase activity. It was also determined that both extracts had no toxic effect on normal cell lines (L-929). Based on pkCSM values, procyanidin B1 and procyanidin B2 compounds have a low volume of distribution, whereas rutin and quercetin compounds have a high volume of distribution (VDss). Not all compounds were predicted to have mutagenic and hepatotoxicity effects. In terms of score and ligand efficiency, procyanidin B1, procyanidin B2, quercetin, and rutin compounds appear to be superior to the reference. The chemicals quercetin and procyanidin B2 are thought to be key players in the pathophysiology of oxidative stress. In this study, the fact that the seeds’ extracts have biological activity and have no toxic effects on normal cell lines suggests that the seeds can be used medicinally and nutritionally in the future.
- 28 October 2024
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 102
Sublingual β-Glucan/Vitamin C-loaded nanoparticle-embedded polyethylene oxide nanofibrous mats
- 28 October 2024
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 102
Sublingual β-Glucan/Vitamin C-loaded nanoparticle-embedded polyethylene oxide nanofibrous mats
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Brazilian Archives of Biology and Technology
- Vol. 67, e24240063
Chemical Composition, in Vitro Bioactivity Evaluation, in Silico Molecular Docking and ADMET Study of Hypericum scabrum and Hypericum triquetrifolium
Medicinal plants of the genus Hypericum L. have been widely used in both traditional and contemporary medicine for many years. According to the literature antimicrobial, anti-urease, anti-crystallization activities and toxicity studies of petroleum ether, chloroform and methanol extracts from H.scabrum and H. triquetrifolium species have not reported yet. The purpose of this study is to investigate the biological activities of the extracts using in vitro and in silico techniques and to evaluate their chemical composition. The pharmacokinetic characteristics of the substances are also to be ascertained. The results showed that the methanol extracts were rich in total phenolic content. The extracts showed potent anti-urease, anti-crystallization and antimicrobial activity. Methanol extracts didn’t show toxicity in the normal cell line (L-929). Also, this work used HPLC-DAD to quantitatively assess the amounts of isorhamnetin, rutin, and chlorogenic acid in methanol extracts from both plants. Docking studies were performed with anticholinesterase, urease, cytochrome P450, lipoxygenase, myeloperoxidase, xanthine oxidase and NADPH enzymes and phenolics by using docking program. With a binding affinity of -10.3 kcal/mol, chlorogenic acid docks to the xanthine oxidase enzyme's active site. Rutin binds to the myeloperoxidase enzyme's active site with a binding affinity of -9,9 kcal/mol. With a binding affinity of -9,4 kcal/mol, the isorhamnetin docks to the active site of the myeloperoxidase enzyme. The drug likeness properties of the phenolics were predicted by SwissADME. According to Lipinski's five guidelines, it was found that the compounds didn’nt exhibit mutagenic and hepatotoxic effects. The findings indicate that methanol extracts exhibit biological activities.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Brazilian Archives of Biology and Technology
- Vol. 67, e24240063
Open AccessChemical Composition, in Vitro Bioactivity Evaluation, in Silico Molecular Docking and ADMET Study of Hypericum scabrum and Hypericum triquetrifolium
Medicinal plants of the genus Hypericum L. have been widely used in both traditional and contemporary medicine for many years. According to the literature antimicrobial, anti-urease, anti-crystallization activities and toxicity studies of petroleum ether, chloroform and methanol extracts from H.scabrum and H. triquetrifolium species have not reported yet. The purpose of this study is to investigate the biological activities of the extracts using in vitro and in silico techniques and to evaluate their chemical composition. The pharmacokinetic characteristics of the substances are also to be ascertained. The results showed that the methanol extracts were rich in total phenolic content. The extracts showed potent anti-urease, anti-crystallization and antimicrobial activity. Methanol extracts didn’t show toxicity in the normal cell line (L-929). Also, this work used HPLC-DAD to quantitatively assess the amounts of isorhamnetin, rutin, and chlorogenic acid in methanol extracts from both plants. Docking studies were performed with anticholinesterase, urease, cytochrome P450, lipoxygenase, myeloperoxidase, xanthine oxidase and NADPH enzymes and phenolics by using docking program. With a binding affinity of -10.3 kcal/mol, chlorogenic acid docks to the xanthine oxidase enzyme's active site. Rutin binds to the myeloperoxidase enzyme's active site with a binding affinity of -9,9 kcal/mol. With a binding affinity of -9,4 kcal/mol, the isorhamnetin docks to the active site of the myeloperoxidase enzyme. The drug likeness properties of the phenolics were predicted by SwissADME. According to Lipinski's five guidelines, it was found that the compounds didn’nt exhibit mutagenic and hepatotoxic effects. The findings indicate that methanol extracts exhibit biological activities.
- 1 October 2023
- Published by Bentham Science Publishers Ltd. in Current Drug Delivery
- Vol. 20 (8) , 1176-1187
Chitosan Modification-Enhanced Silencing Effect of Ad5-shPDGF-D Vector in Breast Cancer Cell Line MDA-MB-231
Background: Gene therapeutics are being developed to treat metastatic breast tumors, which are mostly resistant to conventional therapies. Targeting platelet-derived growth factor-D (PDGF-D) is a viable approach because it is known to play roles in angiogenesis and tumor growth. The success of gene therapy is largely dependent on delivery vectors, but both viral and nonviral delivery vectors have their own disadvantages. Evolving hybrid vectors are being used to overcome those disadvantages. Objectives: In this study, we aimed to prepare a recombinant adenovirus type-5 (Ad5)/chitosan hybrid vector to deliver shPDGF-D in a breast cancer cell line by the noncovalent coating of the Ad5 surface with chitosan, a natural polymer. Methods: The Ad5/chitosan hybrid vector was prepared by the noncovalent coating of the Ad5 surface with different molecular weights (low and high) and different amounts of chitosan (12.5, 25, and 50 µg) and the effect of silencing PDGF-D was investigated in the MDA-MB-231 cell line. Results: In vitro characterization studies showed that the noncovalent chitosan coating increased the size of the Ad5 particle and changed the surface charge from -16.53 mV to slightly neutral. In vitro cell culture studies also showed that the addition of chitosan with both low (73.61%) and high (65.86%) molecular weight increased the PDGF-D silencing efficiency of the Ad5 vector (42.44%) at 48 hours. While low-molecular-weight chitosan had faster effects, high-molecular-weight chitosan provided a more sustained effect in PDGF-D silencing. Conclusion: The results indicate that noncovalent chitosan modification may improve the therapeutic effects of the Ad5 vector, offering potential for further in vitro and in vivo experiments.
- 1 October 2023
- Published by Bentham Science Publishers Ltd. in Current Drug Delivery
- Vol. 20 (8) , 1176-1187
Chitosan Modification-Enhanced Silencing Effect of Ad5-shPDGF-D Vector in Breast Cancer Cell Line MDA-MB-231
Background: Gene therapeutics are being developed to treat metastatic breast tumors, which are mostly resistant to conventional therapies. Targeting platelet-derived growth factor-D (PDGF-D) is a viable approach because it is known to play roles in angiogenesis and tumor growth. The success of gene therapy is largely dependent on delivery vectors, but both viral and nonviral delivery vectors have their own disadvantages. Evolving hybrid vectors are being used to overcome those disadvantages. Objectives: In this study, we aimed to prepare a recombinant adenovirus type-5 (Ad5)/chitosan hybrid vector to deliver shPDGF-D in a breast cancer cell line by the noncovalent coating of the Ad5 surface with chitosan, a natural polymer. Methods: The Ad5/chitosan hybrid vector was prepared by the noncovalent coating of the Ad5 surface with different molecular weights (low and high) and different amounts of chitosan (12.5, 25, and 50 µg) and the effect of silencing PDGF-D was investigated in the MDA-MB-231 cell line. Results: In vitro characterization studies showed that the noncovalent chitosan coating increased the size of the Ad5 particle and changed the surface charge from -16.53 mV to slightly neutral. In vitro cell culture studies also showed that the addition of chitosan with both low (73.61%) and high (65.86%) molecular weight increased the PDGF-D silencing efficiency of the Ad5 vector (42.44%) at 48 hours. While low-molecular-weight chitosan had faster effects, high-molecular-weight chitosan provided a more sustained effect in PDGF-D silencing. Conclusion: The results indicate that noncovalent chitosan modification may improve the therapeutic effects of the Ad5 vector, offering potential for further in vitro and in vivo experiments.
- 11 December 2022
- Published by Wiley in The Journal of Gene Medicine
- Vol. 25 (2) , e3465
Combination therapy with chitosan/siRNA nanoplexes targeting PDGF‐D and PDGFR‐β reveals anticancer effect in breast cancer
Background: Platelet derived growth factors (PDGF)‐D and the expression of its receptor increase in neoplastic progression of cancer. Co‐silencing of growth factor and receptor can be suggested as an important strategy for effective cancer therapy. In the present study, we hypothesized that suppression of PDGF‐D signaling pathway with small interfering RNAs (siRNAs) targeting both PDGF‐D and PDGF receptor (PDGFR)‐β is a promising strategy for anticancer therapy.Methods: Chitosan nanoplexes containing dual and single siRNA were prepared at different weight ratios and controlled by gel retardation assay. Characterization, cellular uptake, gene silencing and invasion studies were performed. The effect of nanoplexes on breast tumor growth, PDGF expression and apoptosis was investigated.Results: We have shown that downregulation of PDGF‐D and PDGFR‐β with chitosan/siRNA nanoplex formulations reduced proliferation and invasion in breast cancer cells. In the in vivo breast tumor model, it was determined that the intratumoral administration of chitosan/siPDGF‐D/siPDGFR‐β nanoplexes markedly decreased the tumor volume and PDGF‐D and PDGFR‐β mRNA and protein expression levels and increased apoptosis.Conclusions: According to the results obtained, we evaluated the effect of PDGF‐D and PDGFR‐β on breast tumor development and showed that RNAi‐mediated inhibition of this pathway formulated with chitosan nanoplexes can be considered as a new breast cancer therapy strategy.
- 11 December 2022
- Published by Wiley in The Journal of Gene Medicine
- Vol. 25 (2) , e3465
Combination therapy with chitosan/siRNA nanoplexes targeting PDGF‐D and PDGFR‐β reveals anticancer effect in breast cancer
Background: Platelet derived growth factors (PDGF)‐D and the expression of its receptor increase in neoplastic progression of cancer. Co‐silencing of growth factor and receptor can be suggested as an important strategy for effective cancer therapy. In the present study, we hypothesized that suppression of PDGF‐D signaling pathway with small interfering RNAs (siRNAs) targeting both PDGF‐D and PDGF receptor (PDGFR)‐β is a promising strategy for anticancer therapy.Methods: Chitosan nanoplexes containing dual and single siRNA were prepared at different weight ratios and controlled by gel retardation assay. Characterization, cellular uptake, gene silencing and invasion studies were performed. The effect of nanoplexes on breast tumor growth, PDGF expression and apoptosis was investigated.Results: We have shown that downregulation of PDGF‐D and PDGFR‐β with chitosan/siRNA nanoplex formulations reduced proliferation and invasion in breast cancer cells. In the in vivo breast tumor model, it was determined that the intratumoral administration of chitosan/siPDGF‐D/siPDGFR‐β nanoplexes markedly decreased the tumor volume and PDGF‐D and PDGFR‐β mRNA and protein expression levels and increased apoptosis.Conclusions: According to the results obtained, we evaluated the effect of PDGF‐D and PDGFR‐β on breast tumor development and showed that RNAi‐mediated inhibition of this pathway formulated with chitosan nanoplexes can be considered as a new breast cancer therapy strategy.